Related Experiment Video
Updated: Feb 19, 2026

04:01
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
2.0K
Environmental PFOS and 6:2 Cl-PFESA Reshape Ferroptosis Vulnerability in Liver Cancer
Jiawei Hong1,2,3,4, Keyi Du1,4,5, Tong Wu1,4,5
1Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Environmental Science & Technology
|February 17, 2026
Summary
Per- and polyfluoroalkyl substances (PFAS) promote cell death in normal cells but protect against it in liver cancer cells. This occurs via a STAT3-GPX4 signaling loop, highlighting risks of PFAS replacements.
Area of Science:
- Environmental Toxicology
- Cancer Biology
- Cell Death Research
Background:
- Ferroptosis, a cell death pathway involving iron and lipid peroxidation, is crucial for health and cancer suppression.
- The impact of environmental pollutants like PFAS on ferroptosis in liver cancer is not well understood.
Purpose of the Study:
- To investigate the effects of PFAS on ferroptosis in hepatocellular carcinoma (HCC) and normal hepatocytes.
- To elucidate the underlying molecular mechanisms of PFAS-induced ferroptosis modulation in HCC.
Main Methods:
- Utilized long-term in vitro and in vivo exposure models with environmentally relevant doses of PFAS.
- Employed multiomics analyses to understand the molecular responses.
- Investigated the role of the STAT3-GPX4 signaling axis.
Main Results:
- PFAS promote ferroptosis in normal hepatocytes but induce resistance in HCC.
- Chronic exposure to PFOS and 6:2 Cl-PFESA enhances ferroptosis resistance in HCC.
- PFAS activate STAT3, upregulating GPX4 and creating a self-sustaining loop that suppresses lipid peroxidation and ferroptosis in HCC.
- 6:2 Cl-PFESA demonstrated stronger effects than PFOS, questioning its safety.
Conclusions:
- PFAS exhibit a dual effect: inducing ferroptosis in normal cells while promoting resistance in HCC via STAT3-GPX4 pathway reprogramming.
- This highlights potential health risks associated with PFAS and their replacements.
- The STAT3-GPX4 axis represents a potential therapeutic target for HCC.
